Start typing to retrieve search suggestions. When suggestions are available use up and down arrows to review and ENTER to select. Continue typing to refine.
Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
Trusted Information Creator
Certified November 2025
{arrow_up} Back to top

Slozem 300mg Capsules

Discontinued
Active Ingredient:
diltiazem hydrochloride
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Letters to HCPs Product Information
{arrow_left}
{arrow_right}
Change of Marketing Authorisation Holder

Slozem® Marketing Authorisations have been transferred to Zentiva Pharma UK Limited who plan to reintroduce Slozem® in the near future. For further information regarding Slozem® reintroduction, please contact Zentiva directly.
Merck
Company image
Address
Merck Serono Ltd, 5 New Square, Bedfont Lakes Business Park, Feltham, Middlesex, TW14 8HA, UK
Medical Information Direct Line
+44 (0)208 818 7373
Telephone
+44 (0)208 818 7200
Fax
+44 (0)208 818 7267
Medical Information Fax
+44 (0)208 818 7274
Medical Information e-mail
[email protected]